KOL Perspectives Perception of mirikizumab in moderatetosevere UCSummaryThis KOL Insight briefing focuses on KOLs views of mirikizumab in moderatetosevere UC.Questions topics Perception of Phase II mirikizumab induction data in UC Perception of mirikizum...
↧